Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021)

  • ID: 3785802
  • Report
  • Region: Global
  • 132 Pages
  • Azoth Analytics
1 of 5
Global Cancer Diagnostics Market is Forecasted to Grow at a CAGR of 8.8% During 2016-2021

FEATURED COMPANIES

  • Abbott Laboratories
  • C. R. Bard Inc.
  • Hologic Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific
  • MORE
"Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021) (By Type: Imaging Tests, Endoscopy, Biopsy, Tumor Marker; By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography; By Region: North America, Latin America, APAC, Europe, MEA)"

Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market.

Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population, where emerging markets are expected to achieve higher growth.

Given the growing demand for early detection of cancer, tumor marker tests are gaining prominence and are projected to witness stronger growth in the coming years.

Growth in the incidences of cancer across the globe is due to the sedentary lifestyle such as increasing tobacco consumption and unhealthy eating habits.

Advancement in genomics has resulted in the growing cancer research, due to which early detection of cancer is gaining popularity.

Global Cancer Diagnostics Market is forecasted to grow at a CAGR of 8.8% during 2016-2021F, on account of rising incidences of cancer globally, along with the increasing technological advancement driven by focus on cancer research

North America region remains the major market followed by Europe in the actual period. In the forecast period, APAC region will witness strong growth driven by countries such as India and China.

According to, Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021), Global Cancer Diagnostics market is projected to exhibit a CAGR of over ~8.8% during 2016-2021. On the basis of market segment, Global Cancer Diagnostics Market has been segmented by type (By Type: Imaging Tests, Endoscopy, Biopsy and Tumor Marker, By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography, By Region: North America, Latin America, APAC, Europe and MEA.)

Scope of the Report

The report provides Segmentation by Type:

- Imaging Tests
- Endoscopy
- Biopsy
- Tumor Marker

The report provides Segmentation by Sub-Type:

- Imaging Tests : MRI, Ultrasound, PET-CT Scan, Mammography

The report provides coverage by Region:

- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa (MEA)

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • C. R. Bard Inc.
  • Hologic Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific
  • MORE
1. Research Methodology

2. Executive Summary

3. Strategic Recommendations
3.1. North America and Europe to drive the Cancer Diagnostic Market
3.2. Lung, Breast, Bowel and Prostrate Cancers to remain the major cause of Cancer Diagnostics
3.3. Cancer Imaging Test would form the largest market segment for Cancer Diagnosis

4. Global Cancer Diagnostics Market: An Overview
4.1. Product Overview
4.1.1. Global Cancer Diagnostics Market, By Value 2011-2015
4.1.2. Global Cancer Diagnostics Market, By Value 2016-2021F Global Cancer Diagnostics Market: By Type (Imaging Tests, Endoscopy, Biopsy, Tumour Marker Tests)
4.1. Global Imaging Tests Market
4.1.1. By Value (Historic 2011-15)
4.1.2. By Value (Forecast 2016E-2021F)
4.1.3. By Sub-Type - Ultrasound, PET-CT Scan, Mammography, MRI (By Value 2016E-2021F)
4.2. Global Endoscopy Cancer Diagnostics Market
4.2.1. By Value (Historic 2011-15)
4.2.2. By Value (Forecast 2016E-2021F)
4.3. Global Biopsy Market
4.3.1. By Value (Historic 2011-15)
4.3.2. By Value (Forecast 2016E-2021F)
4.4. Global Tumour Marker Tests Market
4.4.1. By Value (Historic 2011-15)
4.4.2. By Value (Forecast 2016E-2021F)
4.5. Global Imaging Test Market, By Region, By Value (2016E-2021F)

5. North America Cancer Diagnostics Market: An Overview
5.1. North America Cancer Diagnostics Market
5.1.1. By Value (Historic 2011-15)
5.1.2. By Value (Forecast 2016E-2021F)
5.2. North America Cancer Diagnostics Country Overview - USA, Canada

6. APAC Cancer Diagnostics Market: An Overview
6.1. APAC Cancer Diagnostics Market
6.1.1. By Value (Historic 2011-15)
6.1.2. By Value (Forecast 2016E-2021F)
6.2. APAC Cancer Diagnostics Country Overview - India, China

7. Europe Cancer Diagnostics Market: An Overview
7.1. Europe Cancer Diagnostics Market
7.1.1. By Value (Historic 2011-15)
7.1.2. By Value (Forecast 2016E-2021F)
7.2. Europe Cancer Diagnostics Country Overview -Denmark, UK

8. Latin America Cancer Diagnostics Market: An Overview
8.1. Latin America Cancer Diagnostics Market
8.1.1. By Value (Historic 2011-15)
8.1.2. By Value (Forecast 2016E-2021F)
8.2. Latin America Cancer Diagnostics Country Overview - Chile, Brazil

9. MEA Cancer Diagnostics Market: An Overview
9.1. MEA Cancer Diagnostics Market
9.1.1. By Value (Historic 2011-15)
9.1.2. By Value (Forecast 2016E-2021F)
9.2. MEA Cancer Diagnostics Country Overview - UAE

10. Market Dynamics
10.1. Market Trends & Developments
10.2. Market Drivers
10.3. Challenges

11. Policy Regulations

12. SWOT Analysis

13. Porter Five Force Model

14. Company Profiles
14.1. Abbott Laboratories
14.2. Becton Dickinson and Company
14.3. F. Hoffmann-La Roche AG (Roche Diagnostics)
14.4. General Electric Co (General Healthcare)
14.5. Thermo Fisher Scientific
14.6. Agilent Technologies, Inc.
14.7. Illumina, Inc.
14.8. Hologic Inc.
14.9. C. R. Bard Inc.

15 About us & Disclaimer

List of Figures

Figure 1: Global Cancer Diagnostics Market, 2011-2015 (USD Billion)
Figure 2: Global Population Above 65 Percentage of Total Population
Figure 3: Major Cancer Among Women
Figure 4: Major Cancer Among Men
Figure 5: Estimated Cancer Incidences (approx.14 million) in 2012 with Regional Breakup
Figure 6: Estimated Cancer Mortality (approx. 8 million) in 2012 with Regional Breakup
Figure 7: Global Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
Figure 8: Global Population Above 65 (in Million)
Figure 9: Global Cancer Diagnostic Imaging Test Market, By Value, 2011-2021F (in USD Billion)
Figure 10: Global Imaging Test Market, By Sub-Type, By Value, 2016E (In Percentage)
Figure 11: Global Imaging Test Market, By Sub-Type, By Value, 2021F (In Percentage)
Figure 12: Ultrasound Cancer Diagnostics Market, By Value, 2011-2021F (in USD Million)
Figure 13: PET-CT Scan Market, By Value, 2011-2021F (in USD Million)
Figure 14: Global Mammography Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
Figure 15: MRI Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
Figure 16: Endoscopy Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
Figure 17: Biopsy Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
Figure 18: Tumour Marker Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
Figure 19: Global Imaging Test Market, By Region, By Value, 2016E (In Percentage)
Figure 20: Global Imaging Test Market, By Region, By Value2021F (In Percentage)
Figure 21: North America Cancer Diagnostics Market, 2011-2015 (USD Billion)
Figure 22: North America Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
Figure 23: North America Population Above 65 as Percentage of Total Population
Figure 24: APAC Cancer Diagnostics Market , 2011-2015 (USD Billion)
Figure 25: South Asia Cancer Cases Within Major Countries, 2012
Figure 26: Aging Population in South, East Asia and Pacific (in Percentage)
Figure 27: APAC Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
Figure 28: APAC Population Above 65 as Percentage of Total Population
Figure 29: Europe Cancer Diagnostics Market, 2011-2015 (USD Billion)
Figure 30: Cancer Survival Rates in Europe in 2012 (in Percentage)
Figure 31: Population Above 65 in European Union Region To Total Population (In Percentage)
Figure 32: Europe Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
Figure 33: Europe Population Above 65 as Percentage of Total Population
Figure 34: Latin America Cancer Diagnostics Market, 2011-2015 (USD Million)
Figure 35: Aging Population in Latin America (in Percentage)
Figure 36: Latin America Cancer Diagnostics Market Size, 2016E-2021F (USD Million)
Figure 37: Latin America and Caribbean Population Above 65 as Percentage of Total Population
Figure 38: MEA Cancer Diagnostics Market, 2011-2015 (USD Million)
Figure 39: Estimated Incidences of Cancer in Africa Per 100,000 (Excluding non-melanoma skin cancer)
Figure 40: MEA Cancer Diagnostics Market Size, 2016E-2021F (USD Million)
Figure 41: MEA Population Above 65 as Percentage of Total Population
Figure 42: Incidences of Cancer Globally
Figure 43: Age Group Wise Annual Cases of Cancer between 2009-13 (in Percentage)
Figure 44: Population Above 60 Percentage of the total Population Over the Years
Figure 45: Region Wise and Segment Wise Breakup for GE
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Abbott Laboratories
- Agilent Technologies, Inc.
- Becton Dickinson and Company
- C. R. Bard Inc.
- F. Hoffmann-La Roche AG (Roche Diagnostics)
- General Electric Co (General Healthcare)
- Hologic Inc.
- Illumina, Inc.
- Thermo Fisher Scientific
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll